A. Hansen

发表

Feasibility of a standardized ultrasound examination in patients with rheumatoid arthritis: a quality improvement among rheumatologists cohort

H. Bliddal, S. Torp-Pedersen, R. Christensen, 2012, BMC Musculoskeletal Disorders.

No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study

A. Boonen, M. Østergaard, O. Madsen, 2010, Annals of the rheumatic diseases.

Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CT

L. Terslev, M. Østergaard, M. Szkudlarek, 2012, Annals of the rheumatic diseases.

Which Factors Influence Radiographic Progression During Treatment with Tumor Necrosis Factor Inhibitors in Clinical Practice? Results from 930 Patients with Rheumatoid Arthritis in the Nationwide Danish DANBIO Registry

A. Thormann, N. Graudal, M. Østergaard, 2014, The Journal of Rheumatology.

Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis.

L. Hilsted, M. Lydolph, M. Klose, 2017, European journal of endocrinology.

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

A. Thormann, N. Graudal, M. Østergaard, 2012, Annals of the rheumatic diseases.

Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)

U. Tarp, M. Østergaard, M. Hetland, 2005, Scandinavian journal of rheumatology.

Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trial

L. Dreyer, O. Madsen, A. Hansen, 2021, Clinical Rheumatology.

Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?

M. Østergaard, J. Pødenphant, U. Tarp, 2007, Annals of the rheumatic diseases.

Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database

M. Østergaard, U. Tarp, M. Østergaard, 2007, Scandinavian journal of rheumatology.

Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry

A. Loft, M. Østergaard, U. Tarp, 2012, Annals of the rheumatic diseases.

Association between MRI findings and patient‐reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse

J. Baker, L. Terslev, M. Østergaard, 2020, International journal of rheumatic diseases.

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

M. Østergaard, J. Pødenphant, U. Tarp, 2008, Annals of the rheumatic diseases.

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.

I. Christensen, M. Østergaard, L. Dreyer, 2010, Arthritis and rheumatism.

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.

A. Loft, B. Gudbjornsson, B. Glintborg, 2014, Rheumatology.

Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry

H. Leffers, M. Østergaard, L. Dreyer, 2011, Annals of the rheumatic diseases.

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors

A. Loft, P. Garnero, M. Østergaard, 2011, Annals of the rheumatic diseases.

Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering.

Jan Christensen, M. Østergaard, H. Røgind, 2021, Rheumatology.

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiog

A. Loft, P. Garnero, M. Østergaard, 2011, Arthritis and rheumatism.

Abstracts of the 34th Scandinavian Congress of Rheumatology, Copenhagen, Denmark, September 2nd – 5th, 2012

A. Thormann, N. Graudal, B. Glintborg, 2012, Scandinavian journal of rheumatology. Supplement.

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors

A. Loft, M. Østergaard, K. Asmussen, 2009, Annals of the rheumatic diseases.

Predictive baseline morning P-cortisol levels for the response to a Synacthen test in prednisolone treated patients

L. Hilsted, M. Klose, U. Feldt-Rasmussen, 2017 .

Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage

E. Sasso, C. Brahe, D. Chernoff, 2017, Scandinavian journal of rheumatology.

Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure

A. Boonen, M. Østergaard, O. Madsen, 2008, Annals of the rheumatic diseases.

Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors

L. Terslev, M. Ostergaard, K. Asmussen, 2022, RMD Open.

Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care – 2-year outcomes and predictors

L. Terslev, M. Østergaard, K. Asmussen, 2018, Rheumatology.

Evidence-based recommendations for treatment with methotrexate in rheumatic disorders.

A. Loft, M. Østergaard, B. Baslund, 2010, Danish medical bulletin.

Diagnostic Value of Composite and Simplified FDG-PET/CT Scores in Polymyalgia Rheumatica and the Influence of Recent Glucocorticoid Treatment—A Retrospective Diagnostic Cohort Study

O. Madsen, A. Hansen, L. Brinth, 2023, Diagnostics.

DANISH MEDICAL BULLETIN

A. Loft, M. Østergaard, B. Baslund, 2010 .

A. Boonen, O. Madsen, M. Østergaard, 2008, Annals of the rheumatic diseases.

Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis.

L. Hilsted, M. Lydolph, M. Klose, 2017, European journal of endocrinology.

Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis

H. Røgind, M. Hetland, K. Gosvig, 2023, The Journal of Rheumatology.